KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) EBT Margin (2016 - 2025)

Pfizer (PFE) has disclosed EBT Margin for 17 consecutive years, with 9.35% as the latest value for Q4 2025.

  • Quarterly EBT Margin changed N/A to 9.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 15.6% through Dec 2025, changed N/A year-over-year, with the annual reading at 12.02% for FY2025, 8363.0% down from the prior year.
  • EBT Margin for Q4 2025 was 9.35% at Pfizer, down from 145.08% in the prior quarter.
  • The five-year high for EBT Margin was 1066.74% in Q3 2024, with the low at 120.24% in Q4 2023.
  • Average EBT Margin over 5 years is 93.15%, with a median of 35.27% recorded in 2022.
  • The sharpest move saw EBT Margin skyrocketed 109159bps in 2024, then plummeted -92166bps in 2025.
  • Over 5 years, EBT Margin stood at 32.63% in 2021, then grew by 22bps to 39.76% in 2022, then tumbled by -402bps to 120.24% in 2023, then skyrocketed by 987bps to 1066.74% in 2024, then plummeted by -101bps to 9.35% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 9.35%, 145.08%, and 20.77% for Q4 2025, Q3 2025, and Q2 2025 respectively.